|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/16 | |
| A61K 31/4745 | |||
| A61P 17/00 | |||
| A61P 17/02 | |||
| A61P 17/06 | |||
| A61P 17/10 | |||
| A61P 17/12 | |||
| A61K 38/01 | |||
| A61K 8/49 | |||
| A61K 8/64 | |||
| A61Q 19/06 | |||
| A61Q 19/00 | |||
| A61K 31/437 |
| (11) | Number of the document | 2928485 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13801588.8 |
| Date of filing the European patent application | 2013-12-06 | |
| (97) | Date of publication of the European application | 2015-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/075848 |
| Date | 2013-12-06 |
| (87) | Number | WO 2014/086994 |
| Date | 2014-06-12 |
| (30) | Number | Date | Country code |
| 201261734428 P | 2012-12-07 | US |
| (72) |
SEIFARTH, Federico G., DE
LAX, Julia, DE
|
| (73) |
Alfa Biogene International B.V.,
Industrie Strasse 9, 48455 Bad Bentheim,
DE
|
| (54) | HSP FOR USE IN TREATMENT FOR IMIQUIMOD RELATED SIDE EFFECTS |
| HSP FOR USE IN TREATMENT FOR IMIQUIMOD RELATED SIDE EFFECTS |